How to Help Your Patients Find Azurette 28 Day in Stock: A Provider's Guide

Your Patient Can't Find Azurette — Here's How to Help

It's a familiar scenario for OB/GYN and primary care offices: a patient calls saying their pharmacy can't fill their Azurette 28 Day prescription. They're anxious about going without birth control and want to know what to do. How your practice handles this call can make the difference between a seamless solution and a missed contraceptive cycle.

This guide provides a practical, step-by-step approach for providers and clinical staff to help patients locate Azurette or transition smoothly to an equivalent alternative. For broader context on the supply situation, see our provider shortage briefing.

Current Availability: What You Need to Know

Azurette 28 Day (Desogestrel 0.15 mg / Ethinyl Estradiol 0.02 mg / 0.01 mg) is not on the FDA shortage list and has not been discontinued. However, it is a niche generic with limited manufacturers, which causes inconsistent availability at the pharmacy level.

Key facts for your practice:

• Azurette is produced by a small number of generic manufacturers
• Major chain pharmacies may not stock it, preferring other generics in the same class
• Independent pharmacies often have more stocking flexibility
• Regional availability varies — a pharmacy 10 miles away may have it when the nearest one doesn't
• The situation has been persistent since 2024-2025 and is not expected to change significantly in the near term

Why Patients Can't Find Azurette

Understanding the root causes helps you set realistic expectations with patients:

Limited Manufacturing Base

Unlike widely prescribed generics with 10+ manufacturers, Azurette's specific biphasic Desogestrel/EE formulation has only a few producers. Any disruption at a single facility can affect national supply.

Pharmacy Formulary and Stocking Decisions

Chain pharmacies use algorithms to determine which generics to stock based on local prescription volume. If a location fills more prescriptions for Kariva or Apri, they may not carry Azurette at all. This isn't a shortage — it's a stocking choice.

Insurance Plan Preferences

Insurance formularies may list a different generic (e.g., Viorele or Enskyce) as preferred, which influences which generics pharmacies keep in inventory. Patients prescribed Azurette may face non-formulary status at some pharmacies.

What Providers Can Do: 5 Practical Steps

Step 1: Prescribe Flexibly

Unless there's a specific clinical reason to require Azurette by name, prescribe by the generic name (Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol tablets 0.15 mg/0.02 mg/0.01 mg) without a "dispense as written" (DAW) designation. This allows pharmacists to fill with any AB-rated equivalent — Kariva, Viorele, Pimtrea, or Volnea — without needing to call your office for a new prescription.

Step 2: Direct Patients to Medfinder

Medfinder for Providers offers real-time pharmacy availability data. Train your clinical staff to share this tool with patients who call about availability issues. Patients can search for Azurette 28 Day by zip code and see which local pharmacies have it in stock right now.

Consider adding a note about Medfinder to your patient-facing materials or after-visit summaries for patients on hard-to-find medications.

Step 3: Maintain a Pharmacy Network

Build relationships with 2-3 local independent pharmacies that are willing to stock or special-order niche generics. Keep their contact information readily available for staff. Independent pharmacies can often get Azurette within 1-2 business days through their wholesaler, even when chain pharmacies can't.

Step 4: Pre-authorize Equivalent Substitutions

Add a standing order or note in the patient's chart that permits substitution among Azurette, Kariva, Viorele, Pimtrea, and Volnea. This way, when a pharmacy calls about availability, your staff can approve the switch immediately rather than waiting for a provider callback.

Step 5: Write for 90-Day Supplies

Whenever clinically appropriate and supported by the patient's insurance, prescribe a 90-day supply. This reduces refill frequency and gives patients a buffer against temporary stock disruptions. It also reduces the number of pharmacy calls to your office about this issue.

Alternative Medications to Consider

If a patient needs to switch away from the biphasic Desogestrel/EE formulation entirely, consider these options:

Same Active Ingredient, Different Regimen

• Apri — Desogestrel 0.15 mg / EE 0.03 mg, monophasic 21/7 regimen. Widely available and inexpensive ($9-$15 with coupons). Higher estrogen dose than Azurette.
• Enskyce — Same formulation as Apri. Another widely stocked option.

Different Progestin, Similar Estrogen Dose

• Levonorgestrel/EE combinations (e.g., Aviane, Lutera) — Low-dose EE (0.02 mg) with Levonorgestrel. Very widely available.
• Norethindrone/EE combinations (e.g., Junel Fe, Loestrin Fe) — Available in various estrogen doses.

When switching progestins, counsel patients about the potential for different side effect profiles and recommend 7 days of backup contraception during the transition. For detailed alternatives information, see our alternatives guide.

Workflow Tips for Clinical Staff

Implement these workflows to handle Azurette availability calls efficiently:

Create a Triage Script

When a patient calls about Azurette availability, front-desk and nursing staff can follow this script:

1. Confirm the patient's current prescription and last fill date
2. Check if they have remaining pills (how urgent is this?)
3. Direct them to Medfinder to check nearby pharmacies
4. Offer to send the prescription to a pharmacy that has it in stock
5. If unavailable anywhere, offer to authorize an equivalent substitution (Kariva, Viorele, Pimtrea, Volnea)
6. If switching formulations entirely, schedule a brief provider call

EHR Documentation

Flag patients on Azurette in your EHR with a note about availability challenges and pre-approved substitutions. This speeds up future calls and ensures continuity if different staff members handle the issue.

Proactive Patient Outreach

If your practice has a significant number of patients on Azurette, consider proactive outreach (patient portal message, letter, or call) informing them about potential availability issues, equivalent alternatives, and resources like Medfinder. This reduces reactive calls and improves patient satisfaction.

Final Thoughts

Azurette 28 Day availability issues are a practical challenge, not a clinical crisis — as long as your practice is prepared. By prescribing flexibly, directing patients to real-time availability tools like Medfinder for Providers, maintaining relationships with independent pharmacies, and pre-authorizing equivalent substitutions, you can ensure your patients maintain uninterrupted contraceptive coverage.

The key takeaway: build flexibility into your prescribing and your workflows, and arm your patients with the tools to find their medication. Contraceptive continuity matters, and a little preparation goes a long way.

For cost and savings information to share with patients, see the provider's guide to helping patients save money on Azurette.